作者: Gerald V. Naccarelli , Deborah L. Wolbrette , Luna Bhatta , Mazhar Khan , John Hynes
关键词:
摘要: Clinical trials assessing the efficacy of anti- arrhythmic drugs for terminating atrial fibrillation have demonstrated that rate control little to no added compared placebo; however, spontaneous conversion recent-onset is common. Antiarrhythmic such as oral dofetilide, bolus-flecainide and propafenone intravenous ibutilide all a role in fibrillation. Active comparator amiodarone more efficacious maintaining sinus rhythm than sotalol. Multiple safety amiodarone, sotalol, dofetilide azimilide post-myocardial infarction population congestive heart failure population. Newer antiarrhythmic agents, some with novel mechanisms action, will add pharmacologic armamentarium treating